Individualized Medication Guidance for Prostate Cancer
This test detects 346 genes, including HRR pathway genes. The content involves targeted therapy, immunotherapy, chemotherapy and hereditary risk assessment, and provides comprehensive medication reference for prostate cancer patients.
Features of Individualized Medication Guidance for Prostate Cancer DiagnosisTargeted therapy-Including SNV, InDel, CNV and gene rearrangement, comprehensively guide targeted drug use.
Immunotherapy-Detect TMB and MSI indicators, as well as positive and negative immune-related genes, provide information to guide immunosuppressive therapy.
Chemotherapy- Detect chemotherapeutic drug loci associated with prostate cancer, suggesting sensitivity and toxic side effects of chemotherapeutic drugs.
Hereditary risk assessment- Covering HRR pathway genes, suggesting pathogenic and suspected pathogenic variants, guiding PARP inhibitor therapy, and suggesting genetic risk based on family tumor history and other information.
Applicable Population of Individualized Medication Guidance for Prostate Cancer Prognosis, Prostate Cancer Prevention, Prostate Cancer Therapy
Prostate cancer patients who have relapsed, drug-resistant problem.
Prostate cancer patients who have been diagnosed with prostate cancer, and need liquid biopsy for targeted therapy and immunotherapy.
Late-stage newly diagnosed prostate cancer patients who need targeted therapy and immunotherapy.
If you want to know more details of chemotherapy for prostate cancer, please visit our website.
As an ivd in vitro diagnosticcompany, we can offer sorts of ivd in vitro diagnosticequipment for sale, if you are interested, please leave us a message.
Отправить запрос, связаться с поставщиком
Другие товары поставщика
| Fully Integrated Platform for COVID-19 | The employment of a single system to execute all functions that are capable of being accomplished by the combination of numerous systems is an exam... | |
| CapitalBio® Isothermal Nucleic Acid Amplification Microfluidic Chip Analyzer RTisochip™-A | CapitalBio® Isothermal Nucleic Acid Amplification Microfluidic Chip Analyzer RTisochip™-A and the supporting dish chip are a new platform... | |
| MTB Drug Resistant Detection | The current methods for detecting TB drug resistance are inefficient and imprecise, leading to covering drugs that either cause or exacerbate drug ... | |
| CapitalBio® Microarray Hybridization Station | CapitalBio® Microarray Hybridization Station The CapitalBio® BioMixerTMII is a microarray hybridization station that uses continuous 3-D m... | |
| CapitalBio® DNA Microarray Scanner LuxScan™10K | The CapitalBio LuxScan™ 10K microarray gene array scanner is a compact high performance system for microarray imaging and the analysis of DNA... |
Похожие товары
| Air insulated Dry type transformer VPI | Продавец: Power transformer | Air insulated Dry type transformer VPI TAILI SG(B) air-barrier dry-type transformer( VPI) is des... | |
| Cast Resin Dry Type Transformer with Cooling Fan | Продавец: Power transformer | Cast Resin Dry Type Transformer with Cooling Fan Taili’s advanced epoxy resin casting pr... | |
| 1250kVA Dry type Transformer for Bangladesh | Продавец: Power transformer | 1250kVA Dry type Transformer for Bangladesh Taili's advanced epoxy resin casting process ensures... | |
| 35kV Dry-type transformer with OLTC | Продавец: Power transformer | 35kV Dry-type transformer with OLTC Taili's35kV Dry-type Transformer with OLTC (On-Load Tap Chan... | |
| Cast Resin Dry Type Transformer | Продавец: Power transformer | Cast Resin Dry Type Transformer IEC/ANSICast Resin TransformersfromTAILI Electric, is difference... |















